Política de cookies

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso.

Más información
Permissions Requests - Help - - Sign up - Phone number 902 888 740

2016 FI

© Thomson Reuters, Journal Citation Reports, 2016

Indexed in:

Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME Cancerlit, Bibliomed, CabHealth, Scisearch, HealthStar, Scopus, Prous, Science Intergews, Science Citation Index Expanded.


  • Impact Factor: 1.439 (2016)
  • CiteScore 2017: 1.24
    Read more
  • SCImago Journal Rank (SJR):0,504
  • Source Normalized Impact per Paper (SNIP):0,791

© Thomson Reuters, Journal Citation Reports, 2017

Allergol Immunopathol (Madr) 2016;44:170-6 - DOI: 10.1016/j.aller.2015.05.013
Original Article
Association between ADAM33 S2 and V4 polymorphisms and susceptibility to allergic rhinitis: A meta-analysis
Zewen Lia,, , Fubo Yana, Zhimin Yangb, Jie Zhoua, Yingchao Chena, Zhuhua Dingb
a Department of Otolaryngology, The Central Hospital of Xiaogan, Tongji Medical College, Huazhong University of Science Technology, Xiaogan, Hubei, China
b Department of Otolaryngology, The First People's Hospital of Xiaogan, Zhongnan Hospital of Wuhan University, Xiaogan, Hubei, China
Received 25 February 2015, Accepted 26 May 2015

It has been reported that ADAM33 (a disintegrin and metalloproteinase domain 33) polymorphisms might be associated with susceptibility to allergic rhinitis (AR).


Owing to mixed and inconclusive results, we conducted a meta-analysis to systematically summarise and clarify the association between ADAM33 S2, V4, T1, T2 and T+1 polymorphisms and AR risk.


A systematic search of studies on the association of ADAM33 polymorphisms with susceptibility to AR was conducted in Pubmed and Embase. A total of five case–control studies with 1251 patients and 1634 controls were included. Meta-analysis indicated an association between the ADAM33 S2 and AR in allele comparison (G/C:OR=1.40, 95% CI 1.08–1.82, P=0.012), heterozygote comparison (CG/CC:OR=1.24, 95% CI 1.04–1.48, P=0.015), and dominant comparison (CG+GG/CC:OR=1.39, 95% CI 1.05–1.85, P=0.023). The meta-analysis also revealed an association between the ADAM33 V4 and AR in allele comparison (G/C:OR=1.67, 95% CI 1.01–2.75, P=0.044). However, no association was found between AR and the ADAM33 T1, T2 and T+1 polymorphisms in any gene model comparison.


This meta-analysis demonstrates that the ADAM33 S2 and V4 polymorphisms confer susceptibility to AR. However, these results should be interpreted with caution due to limited sample and heterogeneity. Large-scale and well-designed studies are needed to validate our findings.

ADAM33, Allergic rhinitis, Meta-analysis, Polymorphisms, Susceptibility
Download PDF


Read the complete contents of this article

Already registered?